Korro Bio KRRO
NASDAQ KRRO
$14.47 +0.06 (+0.42%)
As of: Nov 12, 2026 · 2:11 PM EST

Korro Bio (KRRO) Sales of Property, Plant and Equipment (2022 - 2023)

Updated

Analysis

Korro Bio (KRRO) Sales of Property, Plant and Equipment (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Korro Bio 281.05 Mn -128.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 45,000.00
Jun 30, 2023 11,000.00
Mar 31, 2023 7,000.00
Dec 31, 2022 -1,000.00
Sep 30, 2022 18,000.00
API Access

Korro Bio Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=KRRO&period=max&api_key=YOUR_API_KEY